OGN:NYSE
Organon & Co
13,72 USD
arrow_downward
-0,04%(-0,0050) 1D
5-окт., 15:48:20 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for OGN...
Open
13,72 USD
High
13,75 USD
Low
13,70 USD
Mkt. cap
3,60 млд
Avg. vol.
2,76 млн
Volume
1,16 млн
Dividend
0,58%
Quarterly dividend
0,02 USD
Ex-dividend date
2026-ж., 14-авг.
P/E ratio
17,57
52-wk high
13,78 USD
52-wk low
5,69 USD
EPS
0,78 USD
Beta
1,55
Shares outstanding
262,61 млн
No. of employees
10 миң
Open
13,72 USD
High
13,75 USD
Low
13,70 USD
Mkt. cap
3,60 млд
Avg. vol.
2,76 млн
Volume
1,16 млн
Dividend
0,58%
Quarterly dividend
0,02 USD
Ex-dividend date
2026-ж., 14-авг.
P/E ratio
17,57
52-wk high
13,78 USD
52-wk low
5,69 USD
EPS
0,78 USD
Beta
1,55
Shares outstanding
262,61 млн
No. of employees
10 миң
News stories
From web sources and news partners
AD HOC NEWS
·
1 күн мурун
Organon stock presents new VTAMA analysis ahead of November results
Profile
Organon & Co. is an American pharmaceutical company originally founded in Oss, The Netherlands and now headquartered in Jersey City, New Jersey. Organon specializes in the following core therapeutic fields: reproductive medicine, contraception, psychiatry, hormone replacement therapy, and anesthesia. Organon produces all its products outside of the United States but receives a third of its revenue from the United States. Wikipedia
About Organon & Co
CEO-
Employees10 миң
Founded1923
HeadquartersДжерси Сити, Нью Джерси, Америка Кошмо Штаттары
SectorPharmaceutical industry
Websiteorganon.com